A Pilot Study Examining Feasibility and Initial Efficacy of Remotely Delivered Cognitive Adaptation Training.
environmental supports
habit-formation
remote cognitive adaptation training
serious mental illness
Journal
Schizophrenia bulletin open
ISSN: 2632-7899
Titre abrégé: Schizophr Bull Open
Pays: United States
ID NLM: 101770329
Informations de publication
Date de publication:
Jan 2023
Jan 2023
Historique:
medline:
16
10
2023
pubmed:
16
10
2023
entrez:
16
10
2023
Statut:
epublish
Résumé
Cognitive Adaptation Training (CAT) is an evidence-based treatment that uses environmental supports including signs, text messages, checklists, smart pill containers, and the organization of belongings to bypass cognitive and motivational impairments and to cue adaptive behavior in the home or work environment. We developed and tested a remote version of CAT to make the treatment available more broadly. Because CAT is focused on working with the individual in their home environment to establish supports, CAT may not be as easy to translate into an effective virtual treatment as talk-therapies. Fifty-six members of managed care were assigned to or given their treatment preference for CAT or Remote CAT (R-CAT) for 6 months. In-person or virtual pill counts were conducted monthly and assessments of habit-formation, symptoms, functioning, and satisfaction were administered every 2 months by independent raters. Analyses using mixed models with repeated measures focused on pre-planned evaluations of within-group change. Adherence improved significantly in R-CAT, functioning improved significantly in CAT and both groups improved significantly on measures of habit-formation and symptoms across 6 months. Higher functioning individuals appeared to choose R-CAT. Satisfaction with treatment was very high in both groups. R-CAT appears to be a potentially effective treatment, particularly for medication follow-though. However, in contrast to decades of previous research, fewer than 20% of eligible Medicaid recipients agreed to participate in the study. This may have been due to recruitment during and immediately post-pandemic.
Identifiants
pubmed: 37842080
doi: 10.1093/schizbullopen/sgad028
pii: sgad028
pmc: PMC10576524
doi:
Types de publication
Journal Article
Langues
eng
Pagination
sgad028Informations de copyright
Published by Oxford University Press on behalf of the University of Maryland's school of medicine, Maryland Psychiatric Research Center 2023.
Références
Schizophr Bull. 2021 Jan 23;47(1):108-117
pubmed: 32614046
Int J Environ Res Public Health. 2023 Feb 08;20(4):
pubmed: 36833623
Schizophr Bull. 2022 Jan 21;48(1):262-272
pubmed: 34510196
Schizophr Res. 2018 Nov;201:307-314
pubmed: 29807806
Curr Med Res Opin. 2007 Oct;23(10):2305-12
pubmed: 17697454
Am J Psychiatry. 1992 Sep;149(9):1148-56
pubmed: 1386964
Am J Psychiatry. 2000 Aug;157(8):1317-23
pubmed: 10910797
Eur Neuropsychopharmacol. 2014 Feb;24(2):215-22
pubmed: 24359935
Schizophr Bull. 2008 May;34(3):483-93
pubmed: 17932089
Schizophr Bull. 2020 Mar 07;:
pubmed: 32144418
Schizophr Bull. 2013 Sep;39(5):999-1007
pubmed: 23086987
Am J Manag Care. 2017 May 1;23(5):e156-e163
pubmed: 28810130
Trials. 2015 Feb 12;16:49
pubmed: 25887511
Work. 2017;56(4):581-589
pubmed: 28339416
J Clin Psychiatry. 2016 Jun;77(6):764-71
pubmed: 27135986